Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial
Irene Roncero‐Ramos, Francisco M. Gutierrez‐Mariscal, Francisco Gómez-Delgado, Alejandro Villasanta‐Gonzalez, José D. Torres‐Peña, Silvia de la Cruz, Oriol Alberto Rangel-Zúñiga, Raúl M. Luque, José M. Ordovás, Javier Delgado‐Lista, Pablo Pérez‐Martínez, Antonio Camargo, Juan F. Alcalá‐Díaz, José López‐Miranda
Topics & Concepts
Type 2 diabetesMedicineDiabetes mellitusInternal medicineInsulin resistanceGastroenterologyRandomized controlled trialInsulinPioglitazoneEndocrinologyLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseMetabolism, Diabetes, and Cancer